Alkermes plc (ALKS)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600

$45.90

+1.36 (+3.05%)

Close of Nov 06, 2026 · end-of-day data

Source: Alkermes plc's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$745.69M	$903.37M	$1.09B	$1.17B	$1.04B	$1.17B	$1.11B	$1.66B	$1.56B	$1.48B
Cost of revenue	$132.12M	$154.75M	$176.42M	$180.38M	$178.32M	$197.32M	$218.07M	$253.04M	$245.33M	$196.46M
Gross profit	$613.57M	$748.63M	$917.85M	$990.56M	$860.44M	$976.43M	$893.73M	$1.41B	$1.31B	$1.28B
Research & development	$387.15M	$412.89M	$425.41M	$512.83M	$394.59M	$290.92M	$272.70M	$270.81M	$245.33M	$323.96M
Selling, general & admin	$374.13M	$421.58M	$526.41M	$599.45M	$538.83M	$549.61M	$590.75M	$689.75M	$645.24M	$701.52M
Operating income	-$208.66M	-$147.90M	-$99.13M	-$175.48M	-$112.43M	$97.75M	-$6.09M	$414.12M	$420.64M	$253.96M
Interest expense	$14.89M	$12.01M	$15.44M	$13.60M	$8.66M	$11.22M	$13.04M	$23.03M	$22.58M	$12.28M
Pre-tax income	-$214.39M	-$143.27M	-$126.97M	-$197.06M	-$96.54M	$87.73M	-$31.13M	$421.52M	$443.75M	$291.45M
Income tax	-$5.94M	$14.67M	$12.34M	-$436.00K	$14.32M	$11.33M	$2.02M	-$97.64M	$71.61M	$49.79M
Net income	-$208.44M	-$157.94M	-$139.31M	-$196.62M	-$110.86M	-$48.17M	-$158.27M	$355.76M	$367.07M	$241.66M
EBITDA	-$114.41M	-$49.38M	$4.53M	-$95.07M	-$30.57M	$176.40M	$71.77M	$489.05M	$449.17M	$281.12M
EPS (basic)	$-1.38	$-1.03	$-0.90	$-1.25	$-0.70	$-0.30	$-0.97	$2.14	$2.22	$1.47
EPS (diluted)	$-1.38	$-1.03	$-0.90	$-1.25	$-0.70	$-0.29	$-0.97	$2.10	$2.17	$1.43
Diluted shares	151.48M	153.41M	155.11M	157.05M	158.80M	164.75M	163.74M	169.73M	169.20M	168.74M
Gross margin	82.3%	82.9%	83.9%	84.6%	82.8%	83.2%	80.4%	84.8%	84.2%	86.7%
Operating margin	-28.0%	-16.4%	-9.1%	-15.0%	-10.8%	8.3%	-0.5%	24.9%	27.0%	17.2%
Net margin	-28.0%	-17.5%	-12.7%	-16.8%	-10.7%	-4.1%	-14.2%	21.4%	23.6%	16.4%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$186.38M	$191.30M	$266.76M	$203.77M	$272.96M	$337.54M	$292.47M	$457.47M	$291.15M	$388.57M
Short-term investments	$310.86M	$242.21M	$272.53M	$331.21M	$362.07M	$198.77M	$315.99M	$316.02M	$460.52M	$199.65M
Receivables	$191.10M	$233.59M	$292.22M	$257.09M	$275.14M	$313.19M	$287.97M	$332.48M	$384.53M	$334.02M
Inventory	$63.00M	$93.28M	$90.20M	$101.80M	$125.74M	$150.34M	$181.42M	$186.41M	$182.89M	$196.62M
Total current assets	$790.68M	$808.84M	$983.25M	$961.97M	$1.11B	$1.06B	$1.13B	$1.49B	$1.42B	$1.93B
Goodwill	$92.87M	$92.87M	$92.87M	$92.87M	$92.87M	$92.87M	$83.03M	$83.03M	$83.03M	$83.03M
Total assets	$1.73B	$1.80B	$1.83B	$1.81B	$1.95B	$2.02B	$1.96B	$2.14B	$2.06B	$2.49B
Total current liabilities	$211.99M	$291.12M	$339.77M	$391.11M	$438.26M	$471.29M	$497.74M	$520.22M	$465.20M	$543.44M
Short-term debt	$3.00M	$3.00M	$2.84M	$2.84M	$2.84M	$3.00M	$3.00M	$3.00M	—	$0
Long-term debt	$280.67M	$278.44M	$276.46M	$274.30M	$272.12M	$292.80M	$290.27M	$287.73M	—	$0
Total debt	$283.67M	$281.44M	$279.31M	$277.14M	$274.96M	$295.80M	$293.27M	$290.73M	—	$0
Total liabilities	$516.94M	$594.42M	$653.72M	$719.96M	$882.75M	$911.90M	$920.23M	$933.54M	$590.59M	$667.70M
Shareholders' equity	$1.21B	$1.20B	$1.17B	$1.09B	$1.07B	$1.11B	$1.04B	$1.20B	$1.46B	$1.82B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$63.80M	$19.19M	$99.28M	$72.08M	$82.84M	$101.72M	$21.04M	$401.35M	$439.12M	$520.75M
Capital expenditures	$43.66M	$51.30M	$69.43M	$90.94M	$42.22M	$28.02M	$38.26M	$48.05M	$33.48M	$40.42M
Free cash flow	-$107.46M	-$32.11M	$29.85M	-$18.86M	$40.62M	$73.69M	-$17.21M	$353.31M	$405.64M	$480.33M
Investing cash flow	$127.24M	-$18.36M	-$22.20M	-$141.83M	-$11.48M	-$66.20M	-$64.54M	$53.36M	-$111.31M	$295.50M
Financing cash flow	-$58.17M	$4.08M	-$1.62M	$6.76M	-$2.17M	$29.07M	-$1.57M	-$289.71M	-$494.14M	$12.38M
Share buybacks	—	—	—	—	—	—	—	—	$200.28M	—
Stock-based compensation	$94.40M	$83.92M	$105.36M	$100.98M	$90.16M	$87.62M	$94.25M	$100.91M	$96.64M	$98.72M
Depreciation & amortization	$94.26M	$98.52M	$103.66M	$80.41M	$81.85M	$78.65M	$77.86M	$74.93M	$28.53M	$27.16M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$377.48M	$350.37M	$399.13M	$378.14M	$429.99M	$306.51M	$390.66M	$394.19M	$384.55M	$392.91M	$496.01M	$480.13M
Cost of revenue	$70.13M	$58.64M	$61.47M	$63.10M	$62.12M	$49.20M	$49.46M	$51.59M	$46.21M	$61.58M	$98.11M	$94.22M
Gross profit	$307.35M	$291.73M	$337.66M	$315.04M	$367.87M	$257.31M	$341.20M	$342.59M	$338.34M	$331.33M	$397.90M	$385.91M
Research & development	$73.93M	$67.61M	$59.65M	$59.89M	$58.17M	$71.82M	$77.37M	$81.74M	$93.04M	$103.34M	$112.92M	$121.12M
Selling, general & admin	$169.79M	$179.75M	$168.11M	$150.38M	$146.99M	$171.70M	$170.85M	$171.77M	$187.20M	$264.59M	$217.62M	$208.50M
Operating income	$54.63M	$43.31M	$109.88M	$104.76M	$162.69M	$13.79M	$92.98M	$89.08M	$58.10M	-$48.28M	$18.35M	$36.02M
Interest expense	$6.05M	$5.98M	$5.95M	$6.00M	$4.65M	$0	$0	$0	$12.28M	$20.89M	$25.93M	$27.55M
Pre-tax income	$58.32M	$46.91M	$116.72M	$110.23M	$169.89M	$25.49M	$104.84M	$100.75M	$60.38M	-$61.93M	-$1.88M	$14.74M
Income tax	-$102.24M	$7.96M	$22.06M	$17.43M	$24.15M	$3.02M	$17.74M	$17.98M	$11.04M	$4.55M	-$2.38M	-$1.55M
Net income	$112.78M	$36.83M	$91.36M	$92.38M	$146.50M	$22.46M	$87.10M	$82.76M	$49.34M	-$66.48M	$501.00K	$16.29M
EBITDA	$73.17M	$51.37M	$116.54M	$111.73M	$169.53M	$21.21M	$100.80M	$97.16M	$61.95M	-$28.85M	$48.63M	$63.18M
EPS (basic)	$0.68	$0.22	$0.54	$0.57	$0.90	$0.14	$0.53	$0.50	$0.30	$-0.40	$0.00	$0.10
EPS (diluted)	$0.68	$0.21	$0.53	$0.55	$0.87	$0.13	$0.52	$0.49	$0.29	$-0.40	$0.00	$0.09
Diluted shares	-1.25M	172.98M	170.98M	167.03M	-998.00K	168.74M	168.36M	168.51M	298.00K	166.20M	173.48M	176.37M
Gross margin	81.4%	83.3%	84.6%	83.3%	85.6%	83.9%	87.3%	86.9%	88.0%	84.3%	80.2%	80.4%
Operating margin	14.5%	12.4%	27.5%	27.7%	37.8%	4.5%	23.8%	22.6%	15.1%	-12.3%	3.7%	7.5%
Net margin	29.9%	10.5%	22.9%	24.4%	34.1%	7.3%	22.3%	21.0%	12.8%	-16.9%	0.1%	3.4%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$457.47M	$420.75M	$535.15M	$396.29M	$291.15M	$399.81M	$521.20M	$616.45M	$388.57M	$351.55M	$511.53M	$631.31M
Short-term investments	$316.02M	$324.30M	$340.97M	$512.57M	$460.52M	$484.21M	$494.54M	$494.67M	$199.65M	$160.31M	$145.05M	$124.15M
Receivables	$332.48M	$315.85M	$366.42M	$367.21M	$384.53M	$318.70M	$354.91M	$354.39M	$334.02M	$407.63M	$456.48M	$459.09M
Inventory	$186.41M	$198.37M	$194.73M	$191.09M	$182.89M	$183.44M	$191.92M	$191.00M	$196.62M	$336.70M	$298.96M	$261.10M
Total current assets	$1.49B	$1.47B	$1.54B	$1.56B	$1.42B	$1.48B	$1.64B	$1.74B	$1.93B	$1.36B	$1.52B	$1.58B
Goodwill	$83.03M	$83.03M	$83.03M	$83.03M	$83.03M	—	—	—	$83.03M	$596.03M	$594.27M	$592.52M
Total assets	$2.14B	$2.12B	$2.21B	$2.16B	$2.06B	$2.08B	$2.25B	$2.33B	$2.49B	$4.26B	$4.39B	$4.44B
Total current liabilities	$520.22M	$458.98M	$515.55M	$453.70M	$465.20M	$443.73M	$505.96M	$474.36M	$543.44M	$599.50M	$662.09M	$651.93M
Short-term debt	$3.00M	$3.00M	$3.00M	$3.00M	—	—	—	—	$0	$26.50M	$26.50M	$26.50M
Long-term debt	$287.73M	$287.10M	$286.46M	$285.82M	—	—	—	—	$0	$1.48B	$1.48B	$1.47B
Total debt	$290.73M	$290.10M	$289.46M	$288.82M	—	—	—	—	$0	$1.51B	$1.50B	$1.50B
Total liabilities	$933.54M	$869.13M	$922.84M	$863.18M	$590.59M	$570.39M	$628.23M	$596.08M	$667.70M	$2.51B	$2.58B	$2.57B
Shareholders' equity	$1.20B	$1.25B	$1.28B	$1.29B	$1.46B	$1.51B	$1.62B	$1.73B	$1.82B	$1.75B	$1.81B	$1.86B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$107.24M	$21.11M	$146.03M	$81.59M	$190.40M	$98.81M	$150.20M	$101.67M	$170.07M	-$165.74M	$145.18M	$93.48M
Capital expenditures	$17.03M	$8.34M	$7.11M	$8.26M	$9.77M	$10.11M	$13.02M	$17.31M	-$20.00K	$4.09M	$8.15M	$3.40M
Free cash flow	$90.21M	$12.77M	$138.92M	$73.33M	$180.62M	$88.70M	$137.19M	$84.36M	$170.05M	-$169.83M	$137.04M	$90.08M
Investing cash flow	-$20.98M	-$39.95M	$51.85M	-$109.33M	-$13.88M	$9.10M	-$29.21M	-$6.74M	$322.35M	-$2.08B	-$2.41M	$19.99M
Financing cash flow	-$276.50M	-$17.87M	-$83.48M	-$111.11M	-$281.67M	$747.00K	$405.00K	$315.00K	$10.91M	$1.47B	$17.20M	$6.32M
Share buybacks	—	—	—	$115.59M	$1.00K	—	—	$0	—	$27.70M	$0	$0
Stock-based compensation	$25.84M	$32.76M	$20.60M	$22.53M	$20.75M	$22.81M	$24.97M	$24.66M	$26.27M	$36.33M	$31.14M	$26.75M
Depreciation & amortization	$18.54M	$8.06M	$6.66M	$6.97M	$6.85M	$7.42M	$7.82M	$8.08M	$3.85M	$19.43M	$30.28M	$27.16M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.